Thames Ventures VCT 1 (TV1) Competitors GBX 95.50 0.00 (0.00%) (As of 12/19/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividend TV1 vs. BIOG, GSEO, RECI, BOOK, GRID, MTE, BPM, IBT, BGUK, and BRKShould you be buying Thames Ventures VCT 1 stock or one of its competitors? The main competitors of Thames Ventures VCT 1 include The Biotech Growth Trust (BIOG), VH Global Sustainable Energy Opportunities (GSEO), Real Estate Credit Investments (RECI), Literacy Capital (BOOK), Gresham House Energy Storage (GRID), Montanaro European Smaller (MTE), B.P. Marsh & Partners (BPM), International Biotechnology (IBT), Baillie Gifford UK Growth Trust (BGUK), and Brooks Macdonald Group (BRK). These companies are all part of the "asset management" industry. Thames Ventures VCT 1 vs. The Biotech Growth Trust VH Global Sustainable Energy Opportunities Real Estate Credit Investments Literacy Capital Gresham House Energy Storage Montanaro European Smaller B.P. Marsh & Partners International Biotechnology Baillie Gifford UK Growth Trust Brooks Macdonald Group Thames Ventures VCT 1 (LON:TV1) and The Biotech Growth Trust (LON:BIOG) are both small-cap financial services companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, community ranking, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings. Which has more volatility and risk, TV1 or BIOG? Thames Ventures VCT 1 has a beta of 0.12, suggesting that its share price is 88% less volatile than the S&P 500. Comparatively, The Biotech Growth Trust has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500. Which has higher earnings & valuation, TV1 or BIOG? The Biotech Growth Trust has higher revenue and earnings than Thames Ventures VCT 1. Thames Ventures VCT 1 is trading at a lower price-to-earnings ratio than The Biotech Growth Trust, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThames Ventures VCT 1-£3.64M-45.32-£6.72M-£0.04-2,387.50The Biotech Growth Trust£80.35M3.47£74.60M£2.07419.32 Is TV1 or BIOG more profitable? The Biotech Growth Trust has a net margin of 92.85% compared to Thames Ventures VCT 1's net margin of 0.00%. The Biotech Growth Trust's return on equity of 21.57% beat Thames Ventures VCT 1's return on equity.Company Net Margins Return on Equity Return on Assets Thames Ventures VCT 1N/A -7.72% -4.77% The Biotech Growth Trust 92.85%21.57%12.39% Do institutionals & insiders have more ownership in TV1 or BIOG? 28.6% of The Biotech Growth Trust shares are owned by institutional investors. 0.0% of Thames Ventures VCT 1 shares are owned by company insiders. Comparatively, 0.7% of The Biotech Growth Trust shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in TV1 or BIOG? The Biotech Growth Trust received 82 more outperform votes than Thames Ventures VCT 1 when rated by MarketBeat users. CompanyUnderperformOutperformThames Ventures VCT 1N/AN/AThe Biotech Growth TrustOutperform Votes8264.06% Underperform Votes4635.94% Does the media prefer TV1 or BIOG? In the previous week, The Biotech Growth Trust had 1 more articles in the media than Thames Ventures VCT 1. MarketBeat recorded 2 mentions for The Biotech Growth Trust and 1 mentions for Thames Ventures VCT 1. The Biotech Growth Trust's average media sentiment score of 1.96 beat Thames Ventures VCT 1's score of 0.00 indicating that The Biotech Growth Trust is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thames Ventures VCT 1 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral The Biotech Growth Trust 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryThe Biotech Growth Trust beats Thames Ventures VCT 1 on 14 of the 14 factors compared between the two stocks. Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Get Thames Ventures VCT 1 News Delivered to You Automatically Sign up to receive the latest news and ratings for TV1 and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TV1 vs. The Competition Export to ExcelMetricThames Ventures VCT 1Asset Management IndustryFinancial SectorLON ExchangeMarket Cap£164.95M£1.02B£3.63B£1.79BDividend Yield5.21%12.88%4.45%10.92%P/E Ratio-2,387.50784.65420.211,721.77Price / Sales-45.322,036.042,199.83365,146.31Price / CashN/A96.1751.4136.70Price / Book2.081.691.462.84Net Income-£6.72M£64.02M£353.41M£153.82M7 Day PerformanceN/A-1.89%-1.61%-1.87%1 Month Performance135.22%0.14%0.70%16.90%1 Year Performance94.90%7.25%9.94%27.96% Thames Ventures VCT 1 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TV1Thames Ventures VCT 1N/AGBX 95.50flatN/A+94.9%£164.95M£-3,640,000.00-2,387.50N/ANews CoverageBIOGThe Biotech Growth TrustN/AGBX 868.14-0.7%N/A+2.5%£278.93M£80.35M422.22N/AInsider TradeNews CoverageHigh Trading VolumeGSEOVH Global Sustainable Energy OpportunitiesN/AGBX 67.40-1.2%N/A-17.7%£278.48M£21.90M3,170.00N/APositive NewsRECIReal Estate Credit InvestmentsN/AGBX 123.31-0.2%N/A-2.7%£273.62M£31.10M1,235.00N/ANews CoveragePositive NewsBOOKLiteracy CapitalN/AGBX 452+0.8%N/A-6.5%£271.97M£29.26M1,294.856GRIDGresham House Energy StorageN/AGBX 47.40+1.1%N/A-57.4%£269.73M£-100,100,000.00-234.38N/APositive NewsMTEMontanaro European SmallerN/AGBX 141.25-0.2%N/A+2.7%£267.57M£18.23M1,768.75N/ABPMB.P. Marsh & Partners0.6294 of 5 starsGBX 712.78-3.0%GBX 625-12.3%+58.1%£262.66M£51.17M644.7416IBTInternational BiotechnologyN/AGBX 707.76-0.7%N/A+13.2%£261.59M£24.14M1,485.42N/AInsider TradePositive NewsBGUKBaillie Gifford UK Growth TrustN/AGBX 178.32-1.2%N/A+8.1%£258.44M£3.50M16,950.00N/ABRKBrooks Macdonald Group2.3631 of 5 starsGBX 1,609.93-1.2%GBX 2,150+33.5%-9.1%£258.39M£128.26M4,179.49512Gap Up Related Companies and Tools Related Companies BIOG Alternatives GSEO Alternatives RECI Alternatives BOOK Alternatives GRID Alternatives MTE Alternatives BPM Alternatives IBT Alternatives BGUK Alternatives BRK Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:TV1) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Thames Ventures VCT 1 Please log in to your account or sign up in order to add this asset to your watchlist. Share Thames Ventures VCT 1 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TV1 Stock Alerts